Pearson J. Michael 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Dec 28, 2011
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Shares, no par value
2011-12-23−50,997→ 6,144,142 total
Footnotes (2)
- [F1]This number represents common shares withheld from the issuance of common shares to the Reporting Person to satisfy the tax withholding obligations due upon vesting of Matching Restricted Share Units.
- [F2]This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1. This number includes shares underlying equity awards previously reported as withheld to cover tax withholding obligations due on PSUs settled in error in February and April 2011 and subsequently restored.